Company · CIK 2100782
Generate Biomedicines, Inc.
| CIK | 2100782 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | MA |
| Listed | GENB (Nasdaq) |
| First annual or quarterly report | 2026-05-07 |
Offerings
1 registration| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-293204 | 2026-02-04 | 2026-02-27 | 5 |
Filings
6| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-02-27 | 424B4Final prospectus | 333-293204 | 0001193125-26-083190 |
| 2026-02-26 | EFFECTDeclared effective | 333-293204 | 9999999995-26-000677 |
| 2026-02-23 | S-1/AAmendment | 333-293204 | 0001193125-26-062362 |
| 2026-02-13 | S-1/AAmendment | 333-293204 | 0001193125-26-051761 |
| 2026-02-04 | S-1Registration filed | 333-293204 | 0001193125-26-037799 |
| 2025-12-23 | DRSDraft made public | 377-08875 | 0001193125-25-330964 |